Financial statements Aristo Pharma

Balance sheet of Aristo Pharma

Company age:
Age:
20 y. 2 m. 9 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of ARISTO PHARMA

Year
2018
2019
2020
Total assets 24 804 752,20 26 015 967,49 31 318 226,46
A. Fixed assets 9 461 244,59 10 800 619,01 10 086 589,81
B. Current assets 15 343 507,61 15 215 348,48 21 231 636,65
C. Share capital contributions (basic funds) 0,00 - 0,00
D. Own shares (stocks) 0,00 - 0,00
Total liabilities 24 804 752,20 26 015 967,49 31 318 226,46
A. Equity 16 229 349,06 15 060 662,23 14 730 024,07
B. Liabilities and provisions for liabilities 8 575 403,14 10 955 305,26 16 588 202,39
I. Long-term liabilities 2 897 786,63 3 617 426,24 2 650 456,90
II. Short-term liabilities 5 133 669,20 6 409 830,85 12 666 568,30
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.